ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before September 26, 2019. Such persons may also file a written request for a hearing on the application on or before September 26, 2019.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION:
In accordance with 21 CFR 1301.34(a), this is notice that on July 9, 2019, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402 applied to be registered as an importer of the following basic classes of controlled substances:
Controlled substance | Drug code | Schedule |
---|---|---|
3-Fluoro-N-methylcathinone (3-FMC) | 1233 | I |
Cathinone | 1235 | I |
Methcathinone | 1237 | I |
4-Fluoro-N-methylcathinone (4-FMC) | 1238 | I |
Pentedrone (α-methylaminovalerophenone) | 1246 | I |
Mephedrone (4-Methyl-N-methylcathinone) | 1248 | I |
4-Methyl-N-ethylcathinone (4-MEC) | 1249 | I |
Naphyrone | 1258 | I |
N-Ethylamphetamine | 1475 | I |
N,N-Dimethylamphetamine | 1480 | I |
Fenethylline | 1503 | I |
Methaqualone | 2565 | I |
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) | 6250 | I |
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) | 7008 | I |
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone | 7011 | I |
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) | 7012 | I |
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) | 7019 | I |
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) | 7023 | I |
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) | 7024 | I |
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) | 7031 | I |
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) | 7035 | I |
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) | 7048 | I |
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) | 7081 | I |
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) | 7104 | I |
JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) | 7118 | I |
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) | 7122 | I |
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | 7144 | I |
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) | 7173 | I |
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) | 7200 | I |
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) | 7201 | I |
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) | 7203 | I |
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) | 7222 | I |
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) | 7225 | I |
Alpha-ethyltryptamine | 7249 | I |
Ibogaine | 7260 | I |
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) | 7297 | I |
CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) | 7298 | I |
Lysergic acid diethylamide | 7315 | I |
2C-T-7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine | 7348 | I |
Marihuana | 7360 | I |
Parahexyl | 7374 | I |
Mescaline | 7381 | I |
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine ) | 7385 | I |
3,4,5-Trimethoxyamphetamine | 7390 | I |
4-Bromo-2,5-dimethoxyamphetamine | 7391 | I |
4-Bromo-2,5-dimethoxyphenethylamine | 7392 | I |
4-Methyl-2,5-dimethoxyamphetamine | 7395 | I |
2,5-Dimethoxyamphetamine | 7396 | I |
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) | 7398 | I |
3,4-Methylenedioxyamphetamine | 7400 | I |
5-Methoxy-3,4-methylenedioxyamphetamine | 7401 | I |
N-Hydroxy-3,4-methylenedioxyamphetamine | 7402 | I |
3,4-Methylenedioxy-N-ethylamphetamine | 7404 | I |
3,4-Methylenedioxymethamphetamine | 7405 | I |
4-Methoxyamphetamine | 7411 | I |
5-Methoxy-N-N-dimethyltryptamine | 7431 | I |
Alpha-methyltryptamine | 7432 | I |
Bufotenine | 7433 | I |
Diethyltryptamine | 7434 | I |
Dimethyltryptamine | 7435 | I |
Psilocybin | 7437 | I |
Psilocyn | 7438 | I |
5-Methoxy-N,N-diisopropyltryptamine | 7439 | I |
N-Ethyl-1-phenylcyclohexylamine | 7455 | I |
1-(1-Phenylcyclohexyl)pyrrolidine | 7458 | I |
1-[1-(2-Thienyl)cyclohexyl]piperidine | 7470 | I |
N-Benzylpiperazine | 7493 | I |
4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) | 7498 | I |
2C-D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) | 7508 | I |
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) | 7509 | I |
2C-H 2-(2,5-Dimethoxyphenyl) ethanamine) | 7517 | I |
2C-I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) | 7518 | I |
2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) | 7519 | I |
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) | 7521 | I |
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) | 7524 | I |
2C-T-4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) | 7532 | I |
MDPV (3,4-Methylenedioxypyrovalerone) | 7535 | I |
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) | 7536 | I |
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) | 7537 | I |
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) | 7538 | I |
Methylone (3,4-Methylenedioxy-N-methylcathinone) | 7540 | I |
Butylone | 7541 | I |
Pentylone | 7542 | I |
alpha-pyrrolidinopentiophenone (α-PVP) | 7545 | I |
alpha-pyrrolidinobutiophenone (α-PBP) | 7546 | I |
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) | 7694 | I |
Desomorphine | 9055 | I |
Etorphine (except HCl) | 9056 | I |
Codeine methylbromide | 9070 | I |
Heroin | 9200 | I |
Morphine-N-oxide | 9307 | I |
Normorphine | 9313 | I |
Pholcodine | 9314 | I |
U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) | 9547 | I |
AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) | 9551 | I |
Acetylmethadol | 9601 | I |
Allylprodine | 9602 | I |
Alphacetylmethadol except levo-alphacetylmethadol | 9603 | I |
Alphameprodine | 9604 | I |
Alphamethadol | 9605 | I |
Betacetylmethadol | 9607 | I |
Betameprodine | 9608 | I |
Betamethadol | 9609 | I |
Betaprodine | 9611 | I |
Dextromoramide | 9613 | I |
Dipipanone | 9622 | I |
Hydroxypethidine | 9627 | I |
Noracymethadol | 9633 | I |
Norlevorphanol | 9634 | I |
Normethadone | 9635 | I |
Racemoramide | 9645 | I |
Trimeperidine | 9646 | I |
1-Methyl-4-phenyl-4-propionoxypiperidine | 9661 | I |
Tilidine | 9750 | I |
Para-Fluorofentanyl | 9812 | I |
3-Methylfentanyl | 9813 | I |
Alpha-methylfentanyl | 9814 | I |
Acetyl-alpha-methylfentanyl | 9815 | I |
Beta-hydroxyfentanyl | 9830 | I |
Beta-hydroxy-3-methylfentanyl | 9831 | I |
Alpha-methylthiofentanyl | 9832 | I |
3-Methylthiofentanyl | 9833 | I |
Thiofentanyl | 9835 | I |
Methamphetamine | 1105 | II |
Methylphenidate | 1724 | II |
Amobarbital | 2125 | II |
Pentobarbital | 2270 | II |
Secobarbital | 2315 | II |
Glutethimide | 2550 | II |
Nabilone | 7379 | II |
1-Phenylcyclohexylamine | 7460 | II |
Phencyclidine | 7471 | II |
Phenylacetone | 8501 | II |
1-Piperidinocyclohexanecarbonitrile | 8603 | II |
Alphaprodine | 9010 | II |
Dihydrocodeine | 9120 | II |
Ecgonine | 9180 | II |
Ethylmorphine | 9190 | II |
Levomethorphan | 9210 | II |
Levorphanol | 9220 | II |
Meperidine | 9230 | II |
Dextropropoxyphene, bulk (non-dosage forms) | 9273 | II |
Levo-alphacetylmethadol | 9648 | II |
Noroxymorphone | 9668 | II |
Racemethorphan | 9732 | II |
Alfentanil | 9737 | II |
Remifentanil | 9739 | II |
Sufentanil | 9740 | II |
Carfentanil | 9743 | II |
Tapentadol | 9780 | II |
The company plans to import the listed controlled substances for the manufacture of analytical reference standards and distribution to their research and forensic customers. Approval of permit application will occur only when the registrant's activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale.
Dated: August 9, 2019.
Neil D. Doherty,
Acting Assistant Administrator.
[FR Doc. 2019-18455 Filed 8-26-19; 8:45 am]
BILLING CODE 4410-09-P